Recently, Wang et al. showed that the hTREM2 antibody AL002c acted as a TREM2 agonist, promoting the activation of microglia, Aβ phagocytosis, and inhibition of filamentous plaques in a study of AD [26]. The gene discussed is TREM2; the disease is Alzheimer disease.